| Similar Articles |
|---|
 |
Chemistry World
February 14, 2013
Andrew Turley |
BMS sells OTC drugs for $482m UK consumer goods giant Reckitt Benckiser has struck a $482 million deal to buy from Bristol-Myers Squibb rights to a range of over-the-counter drugs in parts of Latin America, including Brazil and Mexico.   |
Chemistry World
November 23, 2012
Andrew Turley |
Schiff seals deal with Reckitt The billion-dollar tussle between German healthcare giant Bayer and UK consumer products firm Reckitt Benckiser over Schiff Nutrition has been resolved with Reckitt winning out. |
The Motley Fool
December 11, 2007
Brian Orelli |
Mucous Migrates East U.K.-based Reckitt Benckiser purchases Adams Respiratory Therapeutics, makers of Mucinex, for $2.3 billion. |
BusinessWeek
July 29, 2010
Sarah Shannon |
Britain's Reckitt Benckiser Goes Shopping The purchase of SSL International, maker of Durex condoms and Scholl foot products, is meant to shore up the consumer product company's revenue growth. |
Wired
April 2005
Douglas McGray |
The Bitter Pill Buprenorphine could end heroin addiction, curb disease, and cut crime. But bureaucrats, doctors, and much of the treatment industry are just saying no. A case study in why the best technology doesn't always win. |
BusinessWeek
January 24, 2005
Laura Cohn |
Why It Pays To Reinvent The Mop U.K.-based Reckitt-Benckiser isn't a household word, but it's a cleaning-products superstar. Its stock has more than doubled since 2000, to $29. |
Chemistry World
November 19, 2012 |
Reckitt steps into Schiff deal Bayer's $1.2 billion bid for Schiff Nutrition, a US company specialising in vitamins and nutritional supplements, could be in trouble following a higher bid from another company. |
American Family Physician
May 1, 2006
Donaher & Welsh |
Managing Opioid Addiction with Buprenorphine Legislation has enabled physicians to treat opioid-dependent patients with an office-based maintenance program using buprenorphine, a partial mu-opioid receptor agonist. |
